298 related articles for article (PubMed ID: 18757438)
1. Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice.
Versteeg HH; Schaffner F; Kerver M; Ellies LG; Andrade-Gordon P; Mueller BM; Ruf W
Cancer Res; 2008 Sep; 68(17):7219-27. PubMed ID: 18757438
[TBL] [Abstract][Full Text] [Related]
2. Role of protease activated receptor 1 and 2 signaling in hypoxia-induced angiogenesis.
Uusitalo-Jarvinen H; Kurokawa T; Mueller BM; Andrade-Gordon P; Friedlander M; Ruf W
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1456-62. PubMed ID: 17363687
[TBL] [Abstract][Full Text] [Related]
3. Protease-activated-receptor-2 affects protease-activated-receptor-1-driven breast cancer.
Jaber M; Maoz M; Kancharla A; Agranovich D; Peretz T; Grisaru-Granovsky S; Uziely B; Bar-Shavit R
Cell Mol Life Sci; 2014 Jul; 71(13):2517-33. PubMed ID: 24177339
[TBL] [Abstract][Full Text] [Related]
4. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
[TBL] [Abstract][Full Text] [Related]
5. Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis.
Shi X; Gangadharan B; Brass LF; Ruf W; Mueller BM
Mol Cancer Res; 2004 Jul; 2(7):395-402. PubMed ID: 15280447
[TBL] [Abstract][Full Text] [Related]
6. Protease-activated receptor 2 (PAR2) is upregulated by Acanthamoeba plasminogen activator (aPA) and induces proinflammatory cytokine in human corneal epithelial cells.
Tripathi T; Abdi M; Alizadeh H
Invest Ophthalmol Vis Sci; 2014 May; 55(6):3912-21. PubMed ID: 24876278
[TBL] [Abstract][Full Text] [Related]
7. PAR1 and PAR2 couple to overlapping and distinct sets of G proteins and linked signaling pathways to differentially regulate cell physiology.
McCoy KL; Traynelis SF; Hepler JR
Mol Pharmacol; 2010 Jun; 77(6):1005-15. PubMed ID: 20215560
[TBL] [Abstract][Full Text] [Related]
8. Determinants of the specificity of protease-activated receptors 1 and 2 signaling by factor Xa and thrombin.
Rana S; Yang L; Hassanian SM; Rezaie AR
J Cell Biochem; 2012 Mar; 113(3):977-84. PubMed ID: 22034092
[TBL] [Abstract][Full Text] [Related]
9. Cooperation of tissue factor cytoplasmic domain and PAR2 signaling in breast cancer development.
Schaffner F; Versteeg HH; Schillert A; Yokota N; Petersen LC; Mueller BM; Ruf W
Blood; 2010 Dec; 116(26):6106-13. PubMed ID: 20861457
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory mediators modulate thrombin and cathepsin-G signaling in human bronchial fibroblasts by inducing expression of proteinase-activated receptor-4.
Ramachandran R; Sadofsky LR; Xiao Y; Botham A; Cowen M; Morice AH; Compton SJ
Am J Physiol Lung Cell Mol Physiol; 2007 Mar; 292(3):L788-98. PubMed ID: 17142351
[TBL] [Abstract][Full Text] [Related]
11. Protease-activated receptor-1 signaling by activated protein C in cytokine-perturbed endothelial cells is distinct from thrombin signaling.
Riewald M; Ruf W
J Biol Chem; 2005 May; 280(20):19808-14. PubMed ID: 15769747
[TBL] [Abstract][Full Text] [Related]
12. Activity of protease-activated receptors in the human submucous plexus.
Mueller K; Michel K; Krueger D; Demir IE; Ceyhan GO; Zeller F; Kreis ME; Schemann M
Gastroenterology; 2011 Dec; 141(6):2088-2097.e1. PubMed ID: 21875497
[TBL] [Abstract][Full Text] [Related]
13. Dual blockade of protease-activated receptor 1 and 2 additively ameliorates diabetic kidney disease.
Mitsui S; Oe Y; Sekimoto A; Sato E; Hashizume Y; Yamakage S; Kumakura S; Sato H; Ito S; Takahashi N
Am J Physiol Renal Physiol; 2020 May; 318(5):F1067-F1073. PubMed ID: 32200667
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional program induced by factor VIIa-tissue factor, PAR1 and PAR2 in MDA-MB-231 cells.
Albrektsen T; Sørensen BB; Hjortø GM; Fleckner J; Rao LV; Petersen LC
J Thromb Haemost; 2007 Aug; 5(8):1588-97. PubMed ID: 17470200
[TBL] [Abstract][Full Text] [Related]
15. Protease-activated receptor-2 (PAR2) mediates VEGF production through the ERK1/2 pathway in human glioblastoma cell lines.
Dutra-Oliveira A; Monteiro RQ; Mariano-Oliveira A
Biochem Biophys Res Commun; 2012 May; 421(2):221-7. PubMed ID: 22497886
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2.
Mize GJ; Wang W; Takayama TK
Mol Cancer Res; 2008 Jun; 6(6):1043-51. PubMed ID: 18567807
[TBL] [Abstract][Full Text] [Related]
17. Statins prevent tissue factor induction by protease-activated receptors 1 and 2 in human umbilical vein endothelial cells in vitro.
Banfi C; Brioschi M; Lento S; Pirillo A; Galli S; Cosentino S; Tremoli E; Mussoni L
J Thromb Haemost; 2011 Aug; 9(8):1608-19. PubMed ID: 21605334
[TBL] [Abstract][Full Text] [Related]
18. Proteinase-activated receptor-1 (PAR1) and PAR2 mediate relaxation of guinea pig internal anal sphincter.
Huang SC
Regul Pept; 2014 Feb; 189():46-50. PubMed ID: 24631471
[TBL] [Abstract][Full Text] [Related]
19. Distinct roles of protease-activated receptors in signal transduction regulation of endothelial nitric oxide synthase.
Suzuki H; Motley ED; Eguchi K; Hinoki A; Shirai H; Watts V; Stemmle LN; Fields TA; Eguchi S
Hypertension; 2009 Feb; 53(2):182-8. PubMed ID: 19064814
[TBL] [Abstract][Full Text] [Related]
20. Transactivation of the PAR1-PAR2 heterodimer by thrombin elicits β-arrestin-mediated endosomal signaling.
Lin H; Trejo J
J Biol Chem; 2013 Apr; 288(16):11203-15. PubMed ID: 23476015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
